Benestermycin, intramaminė suspensija galvijams
Benestermycin, intramaminė suspensija galvijams
Authorised
- Benethamine penicillin
- Framycetin sulfate
- Penethamate hydriodide
Product identification
Medicine name:
Benestermycin, intramaminė suspensija galvijams
Active substance:
- Benethamine penicillin
- Framycetin sulfate
- Penethamate hydriodide
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Benethamine penicillin280.00/milligram(s)1.00Syringe
-
Framycetin sulfate100.00/milligram(s)1.00Syringe
-
Penethamate hydriodide100.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal8day
-
Milk36hourif the cows are injected at least 35 days later. to calving; 37 days after injection if the cows are injected less than 35 days before. before calving
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RC25
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Polyethylene syringes of 5 ml intramuscular suspension in cartons of 20
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Lohmann Pharma Herstellung GmbH
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/97/0538/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV0538.pdf
Lithuanian (PDF)
Download Published on: 2/07/2024
How useful was this page?:
